NANOBIOTIX Stock: Shares Up 6.21% Over the Past Week
Nanobiotix stock closed at €18.48 on Friday, marking a 6.21% increase over the week. This performance significantly outperformed benchmark indices, with the CAC 40 up by 0.19% and the SBF 120 by 0.13% over the same period. Over the past year, the stock has shown an impressive increase of 528.6%.
Weekly Trading Performance
Nanobiotix's share price has followed an upward trajectory over the past five trading sessions. Starting from a level of €17.24 on January 12, the stock progressively climbed to €18.10 on January 13, €18.24 on January 14, €18.38 on January 15, and finally closed at €18.48 on January 16. This weekly rise of 6.21% occurred amidst robust trading volumes, with peaks of 181,161 shares on January 13 and 165,009 shares on January 16, indicating active capital turnover. Over the past year, the stock has soared by 528.6%, confirming a long-term bullish trend despite monthly fluctuations. In comparison, this week has been modest for major Paris indices: the CAC 40 only gained 0.19%, while the SBF 120 advanced by 0.13%. The stock is now trading above its 50-day moving average of €18.42, and well above its 200-day moving average of €10.40, reinforcing the visibility of a positive trend on intermediate horizons. A monthly volatility of 13.36% and a beta of 0.52 indicate moderate sensitivity to general market movements. During this period, the stock explored a high of €18.84 and a low of €16.80, illustrating a certain range of daily exchanges. The last closing at €18.48 positions the stock between a support threshold of €17.24 and a resistance threshold of €19.90, key zones for upcoming movements. This week's rise is supported by consecutive positive sessions, with daily variations ranging from +4.99% on January 13 to +0.54% on January 16, following an initial drop of -2.93% on January 12. The levels reached reflect a firm recovery, driven by increasing liquidity over the days.
Technical Perspective
From a technical standpoint, the stock is positioned above its lower Bollinger Bands at €17.00, while the upper bands peak at €20.18, thus framing recent fluctuations. The RSI indicator at 41 signals a neutral zone, distant from the extremes of overbought or oversold conditions. The MACD line, at -0.08, shows a slight short-term bearish pressure, yet does not reverse the positive weekly momentum. These technical elements outline a chart where the stock consolidates its recent gains around the 50-day moving average. The week's highs and lows, at €18.84 and €16.80 respectively, highlight controlled volatility, with progressive openings: €17.42 on January 12, dipping to €16.92 on January 13 before climbing to €18.34 on January 16. This technical configuration, combined with the exceptional annual performance, positions the stock in a balance between consolidation and potential extension towards the resistance at €19.90. The moving averages confirm a bullish anchor, with the 50-day moving average at €18.42 serving as a pivot close to the current price. Throughout the week, the stock thus outperformed market benchmarks, demonstrating its resilience in a calm stock market context.
